MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE: COV; BSX: COV), a leading global provider of healthcare products, today announced that it is launching a new and improved Magellan™ Safety Hypodermic Needle. The development of the new design, which gives clinicians more control and smoother activation of the safety shield, reflects Covidien’s continued commitment to improving healthcare worker safety.
